<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24937836</article-id>
      <article-id pub-id-type="pmc">4056720</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20142863</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>What Is Your Diagnosis?</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Case for diagnosis<sup><xref ref-type="fn" rid="fn01">*</xref></sup>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Lima</surname>
            <given-names>Louren&#xE7;o de Azevedo</given-names>
          </name>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haddad</surname>
            <given-names>Natacha de Carvalho Mello</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lima</surname>
            <given-names>Ricardo Barbosa</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>D'Acri</surname>
            <given-names>Antonio Macedo</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martins</surname>
            <given-names>Carlos Jos&#xE9;</given-names>
          </name>
        </contrib>
        <aff>Universidade Federal do Estado do Rio de Janeiro (UNIRIO) - Rio de Janeiro
(RJ), Brazil.</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Louren&#xE7;o de Azevedo Lima, Rua Mariz e Barros, 775
- Tijuca, 20270-004 - Rio de Janeiro - RJ, Brazil. E-mail:
<email>louarquivos@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2014</year>
      </pub-date>
      <volume>89</volume>
      <issue>3</issue>
      <fpage>521</fpage>
      <lpage>522</lpage>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>7</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited. </license-p>
        </license>
      </permissions>
      <abstract>
        <p>Degos disease, also known as malignant atrophic papulosis, is a rare occlusive
vasculopathy of unknown etiology characterized by infarcts in the dermis,
gastrointestinal tract, central nervous system, and other organs. It is
characterized by papules, which become umbilicated and evolve with a depressed
porcelain-white central area, with an erythematous halo with telangiectasias.
Histological findings include wedge-shaped dermoepidermal necrosis and blood
vessel thrombosis. Approximately 50-60% of patients with systemic symptoms die
within 2-3 years, most due to gastrointestinal perforation. We report a typical
case, with lethal outcome, in a 45-year-old woman.</p>
      </abstract>
      <kwd-group>
        <kwd>Complement C5</kwd>
        <kwd>Malignant atrophic papulosis</kwd>
        <kwd>Vascular diseases</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>CASE REPORT</title>
      <p>A 45-year-old white female presented with a 1year history of papular lesions,
ulcerations, and scarring on the abdomen, back, and limbs. Six months after symptom
onset, she developed nausea, vomiting, and weight loss of 15 kg. The patient
reported she had been admitted to hospital for abdominal pain and ascites at some
time during the last 3 months. During this hospitalization, exploratory laparotomy
and peritoneal biopsy were performed, with noncontributory findings.</p>
      <p>Physical examination revealed scarring and ulcerations on the chest, back, and
abdomen, as well as papules with a porcelain-white center, some with an erythematous
halo, on the extremities (<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Multiple round scars and ulcerations on the abdomen, as well as an
exploratory laparotomy scar</p>
        </caption>
        <graphic xlink:href="abd-89-03-0521-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Scar with porcelain-white center and ulcerated crusted lesion on the forearm,
each with a halo of erythema</p>
        </caption>
        <graphic xlink:href="abd-89-03-0521-g02"/>
      </fig>
      <p>Laboratory tests, including antinuclear and antiphospholipid antibody titers, were
within normal limits. Histopathological examination of an upper extremity papula
showed thrombosed vascular structures and scant inflammatory cells around the
vessels (<xref ref-type="fig" rid="f03">Figure 3</xref>). The patient was prescribed
acetylsalicylic acid (300 mg/day), dipyridamole (150 mg/day), and enoxaparin (40
mg/day). Her condition improved during the first week of treatment, but she
developed abdominal pain caused by a bowel perforation, and died of sepsis.</p>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Skin biopsy specimen. Epidermis: hyperkeratosis and atrophy of the stratum
spinosum. Dermis: localized necrobiosis with scant cells and absence of
adnexal structures. Thrombo sed blood vessels are visible deep in the derm
is. (H&amp;E stain, original magnification 40x)</p>
        </caption>
        <graphic xlink:href="abd-89-03-0521-g03"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>In view of the clinical and laboratory findings, we established a diagnosis of Degos
disease (DD). DD, also known as malignant atrophic papulosis, is a rare occlusive
vasculopathy of unknown etiology, characterized by infarcts in the dermis,
gastrointestinal tract, central nervous system, and other organs.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref></sup> Two variants have been described: one benign,
confined to the skin, and one malignant, with systemic involvement.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup> The first case was reported by K&#xF6;hlmeier in 1941. DD affects
individuals across all age ranges, but is most common in white young adults; there
is a 3:1 male-to-female predominance.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup></p>
      <p>There are several theories about the pathogenesis of the disease: coagulopathy,
vasculitis, primary endothelial cell disorder, and potential associations with
collagen diseases, genetic factors, and viral infection (parvovirus B19).<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r06" ref-type="bibr">6</xref></sup> Recent studies suggest it is an endotheliopathy,
mediated by C5b-9 deposition and increased cell expression of interferon alpha
leading to vascular changes.<sup><xref rid="r07" ref-type="bibr">7</xref></sup>
Scheinfeld believes DD is a hematologic and/or endothelial condition, possibly
attributable to an acquired, intrinsic genetic defect, and resembles paroxysmal
nocturnal hemoglobinuria, a hematologic disease characterized by an alteration in
the complement system that leads to intravascular hemolysis and
thrombosis.<sup><xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>The diagnosis of DD is mainly clinical. The appearance of the lesions varies
according to the stage of disease progression. The initial lesions are round, pink
papules, approximately 5 mm in diameter, which become umbilicated. In the chronic
stage, these papules develop a porcelain-white central depression and a narrow, pink
peripheral rim with fine telangiectasias. They are distributed predominantly across
the trunk and limbs, and usually spare the scalp and palmoplantar regions.<sup><xref rid="r02" ref-type="bibr">2</xref></sup> The characteristic histological
findings are wedge-shaped dermoepidermal necrosis and vascular thrombosis.<sup><xref rid="r08" ref-type="bibr">8</xref></sup></p>
      <p>DD affects several organs and systems, including the gastrointestinal tract, central
nervous system, cardiopulmonary system, eyes, liver, and kidneys, usually after the
onset of cutaneous lesions.<sup><xref rid="r01" ref-type="bibr">1</xref></sup>
Approximately 50 to 60% of patients with systemic symptoms die within 2 to 3 years,
most due to gastrointestinal perforation. Neurologic and ocular manifestations occur
in 20% and 13% of patients respectively.<sup><xref rid="r08" ref-type="bibr">8</xref></sup></p>
      <p>Several drugs have been used in DD, including topical and systemic corticosteroids,
azathioprine, methotrexate, ciclosporin, tacrolimus, mycophenolate mofetil,
intravenous immunoglobulin, arsenic, sulfonamides, heparin, and warfarin, but none
have produced satisfactory results.<sup><xref rid="r01" ref-type="bibr">1</xref></sup> Recent studies suggest that eculizumab, an anti-C5 monoclonal
antibody, may be a promising alternative.<sup><xref rid="r07" ref-type="bibr">7</xref></sup></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Lima LA, Haddad NCM, Lima RB, D'Acri AM, Martins CJ.
Case for diagnosis. Degos disease: a case report. An Bras Dermatol.
2014;89(3):521-2.</p>
      </fn>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p> Work performed at the Department of Dermatology, Hospital Universit&#xE1;rio Gaffr&#xE9;e
e Guinle da Universidade Federal do Estado do Rio de Janeiro (UNIRIO) - Rio de
Janeiro (RJ), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>NPY</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>PCL</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>CY</given-names>
            </name>
          </person-group>
          <article-title>Malignant atrophic papulosis (Degos' disease)</article-title>
          <source>Hong Kong J Dermatol Venereol</source>
          <year>2008</year>
          <volume>16</volume>
          <fpage>27</fpage>
          <lpage>33</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Buffon</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Georgakilas</surname>
              <given-names>SMF</given-names>
            </name>
            <name>
              <surname>Gatti</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Vidigal</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Criado</surname>
              <given-names>PR</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title xml:lang="pt">Papulose atrofiante maligna (doen&#xE7;a de
Degos)</article-title>
          <source>An Bras Dermatol</source>
          <year>2000</year>
          <volume>75</volume>
          <fpage>201</fpage>
          <lpage>207</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hohwy</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>T&#xF8;ttrup</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Steiniche</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fogh</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>A Fatal Case of Malignant Atrophic Papulosis (Degos' Disease) in
a Man with Factor V Leiden Mutation and Lupus Anticoagulant</article-title>
          <source>Acta Derm Venereol</source>
          <year>2006</year>
          <volume>86</volume>
          <fpage>245</fpage>
          <lpage>247</lpage>
          <pub-id pub-id-type="pmid">16710585</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ball</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Newburger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ackerman</surname>
              <given-names>AB</given-names>
            </name>
          </person-group>
          <article-title>Degos' disease: a distinctive pattern of disease, chiefly of
lupus erythematosus, and not a specific disease per se</article-title>
          <source>Am J Dermatopathol</source>
          <year>2003</year>
          <volume>25</volume>
          <fpage>308</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">12876488</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scheinfeld</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Commentary on Degos Disease A C5b-9/Interferon-a-Mediated
Endotheliopathy Syndrome by Magro et al: A reconsideration of Degos Disease
as hematologic or endothelial genetic disease</article-title>
          <source>Dermatol Online J</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>6</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">21906486</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>High</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Aranda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Cockerell</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Costner</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>Is Degos' disease a clinical and histological end point rather
than a specific disease?</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2004</year>
          <volume>50</volume>
          <fpage>895</fpage>
          <lpage>899</lpage>
          <pub-id pub-id-type="pmid">15153891</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Magro</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Poe</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Nuovo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Crow</surname>
              <given-names>MK</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Degos disease: a C5b-9/interferon-a-mediated endotheliopathy
syndrome</article-title>
          <source>Am J Clin Pathol</source>
          <year>2011</year>
          <volume>135</volume>
          <fpage>599</fpage>
          <lpage>610</lpage>
          <pub-id pub-id-type="pmid">21411783</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ali</surname>
              <given-names>YN</given-names>
            </name>
            <name>
              <surname>Hamed</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Azita</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Lethal systemic Degos disease with prominent cardiopulmonary
involvement</article-title>
          <source>Indian J Dermatol</source>
          <year>2011</year>
          <volume>56</volume>
          <fpage>564</fpage>
          <lpage>567</lpage>
          <pub-id pub-id-type="pmid">22121280</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
